Precision Oncology

Massive Bio, a leading artificial intelligence (AI) analytics company specializing in precision oncology, has been selected by the Precision Cancer…

Shield blood test will be used to evaluate whether blood test option improves adherence to colorectal cancer screening recommendations in…

Glasgow lab will manage blood samples for the SHIELD lung cancer screening study in the EU Sampled1 announced that the new genomics Sampled SMART…

Guardant Health, Inc, a leading precision oncology company, announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by…

AI-Powered Precision Oncology Platform Enables Clinicians to Personalize Cancer Treatment Plans and Overcome Resistance Latest Aithority Insights: …

Adds Vice President of Investor Relations Nextech AR Solutions Corp is pleased to announce the appointment of its new Chief Financial Officer,…

Novellus, a clinical-stage biotechnology company focused on precision oncology, and Tempus, a leader in artificial intelligence and precision…

Collaboration Expands to Include Renal Cell Carcinoma and Prostate Cancer, Including a Focus on Real-World Data Products for Novel Non-Interventional…